Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart hole device shows promise for lung pressure relief

NCT ID NCT03022851

Completed Disease control Sponsor: Occlutech International AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device called the Atrial Flow Regulator (AFR) in 32 people with severe pulmonary hypertension, a condition of high blood pressure in the lungs. The device creates a small, controlled hole in the heart to relieve pressure. The main goal was to check safety and see if the device works to control the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY HYPERTENSION

Contacts and locations

Locations

  • Ankara Etlik Şehir Hastanesi

    Ankara, Yenimahalle, 06170, Turkey (Türkiye)

  • Ege Üniversitesi Tıp Fakültesi Hastanesi

    Izmir, Bornova, 35100, Turkey (Türkiye)

  • Gdański Uniwersytet Medyczny

    Gdansk, 80-952, Poland

  • Hacettepe Üniversitesi Tıp Fakültesi

    Ankara, Altındağ, 06230, Turkey (Türkiye)

  • Justus-Liebig Universität

    Giesen, 35385, Germany

  • Klinikum der Universität München

    Munich, Bavaria, 81377, Germany

  • Kocaeli Üniversitesi Araştırma ve Uygulama Hastanesi

    Kocaeli, Turkey (Türkiye)

  • Sağlık Bilimleri Üniversitesi Tepecik Eğitim ve Araştırma Hastanesi

    Izmir, Konak, 35020, Turkey (Türkiye)

  • Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego

    Poznan, 61-848, Poland

  • Szpital im. Fryderyka Chopina

    Otwock, 05-400, Poland

  • Universitätsklinikum Würzburg

    Würzburg, 97080, Germany

  • Uniwersytet Jagielloński Collegium Medicum

    Krakow, 31-202, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.